Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01521143
What this trial is testing

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment

Who this might be right for
Epithelial Ovarian Cancer
Prima BioMed Ltd 91
Large-scale testing (Phase 3)Study completedNCT00306787
What this trial is testing

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

Who this might be right for
Genital Herpes
Novartis Pharmaceuticals 1,179
Not applicableNot Yet RecruitingNCT07032116
What this trial is testing

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Who this might be right for
Diabetic Kidney Disease (DKD)
Liu Hongfang 4,472
Testing effectiveness (Phase 2)Study completedNCT05634499
What this trial is testing

Giredestrant in Participants With Grade 1 Endometrial Cancer

Who this might be right for
Endometrial Cancer
Hoffmann-La Roche 33
Large-scale testing (Phase 3)Study completedNCT00343616
What this trial is testing

Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98

Who this might be right for
Breast CancerCognitive/Functional EffectsFatigue+1 more
ETOP IBCSG Partners Foundation 135
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT07564232
What this trial is testing

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 40
Early research (Phase 1)Active Not RecruitingNCT06539338
What this trial is testing

Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment

Who this might be right for
Lymphomas Non-Hodgkin's B-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Kite, A Gilead Company 10
Testing effectiveness (Phase 2)Study completedNCT02225652
What this trial is testing

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Who this might be right for
Women With Primary Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 11
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Looking for participantsNCT06714006
What this trial is testing

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PYC Therapeutics 166
Early research (Phase 1)Study completedNCT02903914
What this trial is testing

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more
Incyte Corporation 260
Early research (Phase 1)Study completedNCT01404806
What this trial is testing

GSK1349572 Exposure in Blood, Cervicovaginal Fluid, and Cervical and Vaginal Tissue in Healthy Female Subjects

Who this might be right for
Healthy Adult Females
University of North Carolina, Chapel Hill 10
Early research (Phase 1)Ended earlyNCT04301011
What this trial is testing

Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors

Who this might be right for
Solid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+6 more
Turnstone Biologics, Corp. 27
Early research (Phase 1)WithdrawnNCT00742534
What this trial is testing

Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants

Who this might be right for
Bronchopulmonary Dysplasia
Vanderbilt University
Early research (Phase 1)Study completedNCT03776539
What this trial is testing

Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02

Who this might be right for
Impaired Renal Function
Eloxx Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Early research (Phase 1)Looking for participantsNCT07334119
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Who this might be right for
HER2-Expressing Solid Tumors
Myeloid Therapeutics 60
Not applicableStudy completedNCT01590212
What this trial is testing

Mellow Bumps RCT - Antenatal Intervention for Vulnerable Women

Who this might be right for
Mental Health Wellness 1PregnancyMother-Child Relations
University of Glasgow 35
Testing effectiveness (Phase 2)Looking for participantsNCT07579936
What this trial is testing

A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

Who this might be right for
Postmenopausal Women With Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd. 200
Next Page